Bacterial Membrane Coating Potentiates Lipid Nanoparticles for mRNA Delivery.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41284821.
- Also identified by DOI 10.1021/acs.nanolett.5c04371.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bacterial outer membrane vesicles (OMVs) possess intrinsic immunostimulatory properties by carrying native antigens and pathogen-associated molecular patterns (PAMPs). Lipid nanoparticles (LNPs) have become the leading platform for messenger ribonucleic acid (mRNA) delivery, underpinning the clinical success of mRNA vaccines. Here, we developed a hybrid nanoparticle formulation, OMV-coated LNPs (OMV-LNPs), that combines the high delivery efficiency of LNPs with the immunogenicity of the OMVs to enhance gene delivery. Using <i>Escherichia coli</i>-derived OMVs and dengue virus (DENV) E80 protein as a model antigen, we generated OMV-LNPs encapsulating DENV mRNA (OMV-LNP<sub>mRNA</sub>). These nanoparticles demonstrated improved uptake by lymph-node-resident immune cells and enhanced cytosolic mRNA delivery, resulting in robust dendritic cell maturation and proinflammatory cytokine production <i>in vitro</i>. In AG129 mice, the OMV-LNP<sub>mRNA</sub> elicited significantly higher titers of DENV-neutralizing antibodies compared to conventional LNPs. Collectively, these results establish OMV-LNPs as a versatile and potent platform for effective mRNA vaccine delivery.
Medical subject headings
- Nanoparticles
- RNA, Messenger
- Lipids
- Bacterial Outer Membrane